Adam Graybill

Adam Graybill is the CEO and co-Founder of Journey Biosciences, Inc., where tenure began in April 2021. In addition, Adam serves as a Health Transformer at StartUp Health since February 2023. Previously, Adam was a member of the Board of Directors for the Northeast Ohio Chapter of JDRF International from September 2016 to December 2020 and held multiple roles at Cardinal Health from March 2013 to September 2020, including Vice President Sales and Head of the Diabetes Franchise. Adam also served as General Manager and Diabetes Franchise Head at Assuramed, Inc. from December 2010 to March 2013 and contributed to commercial leadership at Edgepark between June 2004 and November 2010. Adam's educational background includes participation in the Founder University Cohort 27 at Launch.Co and a Fellowship at Startup Health, alongside a Bachelor of Arts in Sports Marketing from Bowling Green State University.